NASDAQ:DRIO DarioHealth (DRIO) Stock Price, News & Analysis $0.55 -0.02 (-4.03%) Closing price 08/1/2025 03:56 PM EasternExtended Trading$0.54 -0.01 (-1.62%) As of 08/1/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About DarioHealth Stock (NASDAQ:DRIO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DarioHealth alerts:Sign Up Key Stats Today's Range$0.53▼$0.5950-Day Range$0.55▼$0.7252-Week Range$0.50▼$1.55Volume116,368 shsAverage Volume173,314 shsMarket Capitalization$24.45 millionP/E RatioN/ADividend YieldN/APrice Target$2.00Consensus RatingModerate Buy Company Overview DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Read More DarioHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreDRIO MarketRank™: DarioHealth scored higher than 37% of companies evaluated by MarketBeat, and ranked 704th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingDarioHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageDarioHealth has only been the subject of 1 research reports in the past 90 days.Read more about DarioHealth's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for DarioHealth are expected to grow in the coming year, from ($1.18) to ($1.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DarioHealth is -0.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DarioHealth is -0.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDarioHealth has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about DarioHealth's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.66% of the outstanding shares of DarioHealth have been sold short.Short Interest Ratio / Days to CoverDarioHealth has a short interest ratio ("days to cover") of 19, which indicates bearish sentiment.Change versus previous monthShort interest in DarioHealth has recently decreased by 4.52%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDarioHealth does not currently pay a dividend.Dividend GrowthDarioHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted6.66% of the outstanding shares of DarioHealth have been sold short.Short Interest Ratio / Days to CoverDarioHealth has a short interest ratio ("days to cover") of 19, which indicates bearish sentiment.Change versus previous monthShort interest in DarioHealth has recently decreased by 4.52%, indicating that investor sentiment is improving. News and Social MediaN/ANews SentimentN/A Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DarioHealth insiders have not sold or bought any company stock.Percentage Held by Insiders11.20% of the stock of DarioHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.39% of the stock of DarioHealth is held by institutions.Read more about DarioHealth's insider trading history. Receive DRIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address DRIO Stock News HeadlinesCovalon Technologies (OTCMKTS:CVALF) vs. DarioHealth (NASDAQ:DRIO) Financial SurveyJuly 26, 2025 | americanbankingnews.comDario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers NationwideJune 26, 2025 | prnewswire.comNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being quietly opened to the public, and former hedge fund firm manager Whitney Tilson believes this is the best chance in years to turn a small stake into huge gains. He's naming one $10 stock leading this "US: IPO" boom. | Stansberry Research (Ad)Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health FindingsJune 24, 2025 | prnewswire.comLitchfield Hills Initiates Coverage of DarioHealth (DRIO) with Buy RecommendationMay 20, 2025 | msn.comEarnings call transcript: DarioHealth Q1 2025 sees EPS beat, stock dipsMay 16, 2025 | uk.investing.comDarioHealth Corp. (DRIO) Q1 2025 Earnings Call TranscriptMay 16, 2025 | seekingalpha.comDarioHealth Corp. (NASDAQ:DRIO) Q1 2025 Earnings Call TranscriptMay 16, 2025 | msn.comSee More Headlines DRIO Stock Analysis - Frequently Asked Questions How have DRIO shares performed this year? DarioHealth's stock was trading at $0.7861 at the beginning of the year. Since then, DRIO shares have decreased by 30.0% and is now trading at $0.5499. How were DarioHealth's earnings last quarter? DarioHealth Corp. (NASDAQ:DRIO) posted its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.07. The firm earned $6.75 million during the quarter, compared to analyst estimates of $7.48 million. DarioHealth had a negative net margin of 159.80% and a negative trailing twelve-month return on equity of 65.81%. Read the conference call transcript. Does DarioHealth have any subsidiaries? The following companies are subsidiaries of DarioHealth: PsyInnovations Inc., Upright Technologies Ltd., Labstyle Innovation Ltd., PsyInnovations India Private Limited., and Upright Technologies Inc.. How do I buy shares of DarioHealth? Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DarioHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that DarioHealth investors own include NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Tesla (TSLA). Company Calendar Last Earnings5/14/2025Today8/02/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:DRIO CIK1533998 Webwww.mydario.com Phone(833) 914-3796Fax972-4770-4059Employees200Year Founded2011Price Target and Rating Average Price Target for DarioHealth$2.00 High Price Target$3.00 Low Price Target$1.00 Potential Upside/Downside+263.7%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$42.75 million Net Margins-159.80% Pretax Margin-159.22% Return on Equity-65.81% Return on Assets-38.41% Debt Debt-to-Equity Ratio0.26 Current Ratio2.01 Quick Ratio1.77 Sales & Book Value Annual Sales$27.04 million Price / Sales0.90 Cash FlowN/A Price / Cash FlowN/A Book Value$2.11 per share Price / Book0.26Miscellaneous Outstanding Shares44,460,000Free Float39,484,000Market Cap$24.45 million OptionableOptionable Beta1.24 Social Links Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:DRIO) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhy “The Prophet” Is Betting Big on This $10 StockAmerica's Biggest Land Grab Is Not Where You Think While the media focuses on coastal cities and farmland.....Stansberry Research | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DarioHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DarioHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.